Sujet

Cancer

Latest breakthroughs in cancer research, treatment, and prevention

602 articles

Telomerase Vaccine Plus Checkpoint Blockade Targets HPV-Driven Cancers
Cancer Research

Telomerase Vaccine Plus Checkpoint Blockade Targets HPV-Driven Cancers

A completed Phase 2 trial tests UCPVax cancer vaccine combined with atezolizumab in cervical, anal, and head-and-neck cancers.

Essai clinique
10 mai 2026 0
Colonoscopy's Cancer Prevention Value Gets a Critical Reassessment
Cancer Research

Colonoscopy's Cancer Prevention Value Gets a Critical Reassessment

A Lancet commentary reexamines the true preventive benefit of colonoscopy screening, challenging assumptions about how we calculate cancer risk reduction.

Article de recherche
10 mai 2026 0
Triple Combo Therapy Targets Chemo-Resistant Colorectal Cancer in Phase I Trial
Cancer Research

Triple Combo Therapy Targets Chemo-Resistant Colorectal Cancer in Phase I Trial

A completed phase I trial tests regorafenib plus dual checkpoint inhibitors in 39 patients with hard-to-treat metastatic colorectal cancer.

Essai clinique
9 mai 2026 0
Checkpoint Immunotherapy Targets CDK12-Mutant Metastatic Cancers in Phase 2 Trial
Cancer Research

Checkpoint Immunotherapy Targets CDK12-Mutant Metastatic Cancers in Phase 2 Trial

A completed Phase 2 trial tests nivolumab plus ipilimumab in CDK12-mutant metastatic prostate and solid tumors across 56 patients.

Essai clinique
9 mai 2026 0
Cancer Stem Cells Use Tiny Vesicles to Shield Tumors from Immune Attack
Cancer Research

Cancer Stem Cells Use Tiny Vesicles to Shield Tumors from Immune Attack

A novel immune-evasion mechanism in triple-negative breast cancer reveals how cancer stem cells suppress anti-tumor immunity via extracellular vesicles.

Article de recherche
9 mai 2026 0
New Immunotherapy Combo Achieves Durable Remissions in Treatment-Resistant Pancreatic Cancer
Cancer Research

New Immunotherapy Combo Achieves Durable Remissions in Treatment-Resistant Pancreatic Cancer

A triple immunotherapy unlocks anti-tumor CD4+ T cells — not CD8+ — to clear pancreatic tumors in mice, reshaping the immunotherapy playbook.

Article de recherche
9 mai 2026 0
Long-Term Randomized Data Reveals Cumulative Urinary Toxicity Risks After Prostate Radiation
Cancer Research

Long-Term Randomized Data Reveals Cumulative Urinary Toxicity Risks After Prostate Radiation

High-level randomized evidence quantifies genitourinary toxicity burden over time following prostate radiotherapy, with direct implications for treatment decisions.

Article de recherche
9 mai 2026 0
Dual EGFR-TGFβ Blockade Achieves 54% Response Rate in Hard-to-Treat Head and Neck Cancer
Cancer Research

Dual EGFR-TGFβ Blockade Achieves 54% Response Rate in Hard-to-Treat Head and Neck Cancer

Ficerafusp alfa plus pembrolizumab shows striking results in HPV-negative head and neck cancer, a notoriously difficult-to-treat population.

Article de recherche
9 mai 2026 0
Four Leukemic Stem Cell Subtypes Explain Venetoclax Resistance in AML
Cancer Research

Four Leukemic Stem Cell Subtypes Explain Venetoclax Resistance in AML

Researchers identify four LSC subtypes that predict venetoclax resistance and reveal matched subtype-specific therapies for AML patients.

Article de recherche
9 mai 2026 0
AI Radiomics May Detect Pancreatic Cancer Before It Becomes Visible
Cancer Research

AI Radiomics May Detect Pancreatic Cancer Before It Becomes Visible

A new editorial in Gut explores how AI-powered radiomic analysis could identify occult pancreatic cancer missed by standard imaging.

Article de recherche
9 mai 2026 0
Single Colonoscopy Cuts Colorectal Cancer Risk 19% Over 13 Years But Misses Mortality Target
Cancer Research

Single Colonoscopy Cuts Colorectal Cancer Risk 19% Over 13 Years But Misses Mortality Target

The landmark NordICC trial's 13-year data shows one colonoscopy meaningfully reduces cancer incidence but doesn't significantly lower mortality.

Article de recherche
9 mai 2026 0
Hidden Blood-Brain Barrier in Lung Cancer Blocks Immunotherapy From Working
Cancer Research

Hidden Blood-Brain Barrier in Lung Cancer Blocks Immunotherapy From Working

Researchers discover a BBB-like vascular shield in small cell lung cancer that blocks immune cells — and find a drug combo to overcome it.

Article de recherche
9 mai 2026 0
PreviousPage 14 of 51Next